4//SEC Filing
Bar-Shalev Amos 4
Accession 0001385113-25-000005
CIK 0001006281other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:34 PM ET
Size
5.9 KB
Accession
0001385113-25-000005
Insider Transaction Report
Form 4
Bar-Shalev Amos
Director
Transactions
- Sale
Common Stock
2025-11-18$1.87/sh−168$314→ 0 total
Holdings
- 7,500(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended must be registered in the name of a trustee.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385113
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:34 PM ET
- Size
- 5.9 KB